Wells Fargo’s BioAmber Inc. BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-27,535
Closed -$13K 6697
2017
Q3
$13K Hold
27,535
﹤0.01% 5823
2017
Q2
$71K Sell
27,535
-5,000
-15% -$11.5K ﹤0.01% 5302
2017
Q1
$75K Sell
32,535
-59,659
-65% -$227K ﹤0.01% 5312
2016
Q4
$507K Buy
92,194
+33,801
+58% +$162K ﹤0.01% 4194
2016
Q3
$247K Buy
58,393
+18,844
+48% +$69.6K ﹤0.01% 4355
2016
Q2
$117K Buy
39,549
+9,964
+34% +$36.4K ﹤0.01% 4725
2016
Q1
$124K Sell
29,585
-272
-0.9% -$1.14K ﹤0.01% 4693
2015
Q4
$185K Sell
29,857
-11,366
-28% -$85.6K ﹤0.01% 4513
2015
Q3
$220K Sell
41,223
-1,383
-3% -$9.13K ﹤0.01% 4416
2015
Q2
$367K Buy
42,606
+14,100
+49% +$129K ﹤0.01% 4270
2015
Q1
$248K Sell
28,506
-1,477
-5% -$13K ﹤0.01% 4324
2014
Q4
$252K Buy
29,983
+7,966
+36% +$72.5K ﹤0.01% 4315
2014
Q3
$220K Buy
22,017
+4,839
+28% +$56.6K ﹤0.01% 4309
2014
Q2
$171K Sell
17,178
-1,053
-6% -$10.9K ﹤0.01% 4442
2014
Q1
$208K Buy
+18,231
New +$216K ﹤0.01% 4315

Other funds holding BIOA

Wells Fargo's BIOA Position: Q4 2017 in Review

Wells Fargo sold out of BioAmber Inc. (BIOA) in Q4 2017, closing a stake of 27,535 shares — an estimated $13K sold.

Wells Fargo first reported a position in BIOA in Q1 2014 and held it in 15 quarters. The position peaked at $507K in Q4 2016. 26 funds tracked by Wall St. Rank hold BIOA as of Q4 2017.

  • Wells Fargo reported no remaining BioAmber Inc. position as of Q4 2017 after selling out during the quarter.
  • Wells Fargo sold 27,535 BioAmber Inc. shares in Q4 2017, an estimated $13K.
  • Wells Fargo first reported a position in BioAmber Inc. in Q1 2014 and held it in 15 quarters.
  • Wells Fargo's BioAmber Inc. position peaked at $507K in Q4 2016.
  • 26 funds tracked by Wall St. Rank held BioAmber Inc. as of Q4 2017.

Based on Wells Fargo's 13F filing for Q4 2017, filed 8 Feb 2018.